Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study - McDonnell, David P; Landry, John; Detke, Holland C (International clinical psychopharmacology, 2014)
Keywords: Adolescent; Adult; Aged; Antipsychotic Agents - adverse effects; Antipsychotic Agents - blood; Antipsychotic Agents - therapeutic use; Benzodiazepines - adverse effects; Benzodiazepines - pharmacokinetics; Benzodiazepines - therapeutic use; Blood Glucose - drug effects; Body Weight - drug effects; Cholesterol - blood; Delayed-Action Preparations - adverse effects; Delayed-Action Preparations - therapeutic use; Delirium - chemically induced; Delirium - complications; Double-Blind Method; Female; Humans; Injections, Intramuscular; International Cooperation; Male; Middle Aged; Psychotic Disorders - blood; Psychotic Disorders - complications; Psychotic Disorders - drug therapy; Quality of Life; Schizophrenia - blood; Schizophrenia - complications; Schizophrenia - drug therapy; Treatment Outcome; Triglycerides - blood; Young Adult